• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunohistochemical and ultrastructural localization of tissue polypeptide antigen in human ovarian tumours.

作者信息

Ghazizadeh M

机构信息

Central Institute for Electron Microscopic Researches, Nippon Medical School, Tokyo, Japan.

出版信息

Virchows Arch A Pathol Anat Histopathol. 1989;414(5):453-7. doi: 10.1007/BF00718630.

DOI:10.1007/BF00718630
PMID:2499102
Abstract

Forty specimens of benign and malignant ovarian tumours were studied for localization of tissue polypeptide antigen (TPA) at light and electron microscopic levels by an indirect immunoperoxidase technique. Of the 30 ovarian carcinomas, 23 (77%) were positive and 7 (23%) were negative for TPA, while of the 10 benign ovarian tumours 3 (30%) were positive and 7 (70%) were negative. Positive reaction did not correlate with the tumour grade. Of the 10 patients with metastasis, 8 (80%) had positive tumours. Staining for TPA was observed at the intraluminal cell surfaces and peripheral cell membranes. The ultrastructural localization of TPA revealed electron-dense reaction products at the cell surface and microvillous surfaces. These results provide confirmatory and supplementary evidence to support the previous findings of TPA in the serum and suggest that testing for TPA in ovarian tumors has a limited prognostic importance and a poor diagnostic value. The surface property of TPA suggests that the cell membrane is involved in secretion and probably synthesis of TPA.

摘要

相似文献

1
Immunohistochemical and ultrastructural localization of tissue polypeptide antigen in human ovarian tumours.
Virchows Arch A Pathol Anat Histopathol. 1989;414(5):453-7. doi: 10.1007/BF00718630.
2
Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours.
Histopathology. 1990 Aug;17(2):123-8. doi: 10.1111/j.1365-2559.1990.tb00682.x.
3
Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors.T抗原在卵巢肿瘤中的免疫组织化学及超微结构定位
Am J Clin Pathol. 1990 Mar;93(3):315-21. doi: 10.1093/ajcp/93.3.315.
4
Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.妇科良恶性疾病中血清组织多肽抗原(TPA)和癌抗原125(CA125)水平的关系及其免疫组织化学鉴定
Arch Gynecol Obstet. 1988;243(1):41-50. doi: 10.1007/BF00931550.
5
Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.与CA125、CA19-9、TPA、IAP、CEA和铁蛋白相比,唾液酸化SSEA-1抗原作为卵巢癌肿瘤标志物的临床应用价值。
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):217-24.
6
The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.组织多肽抗原在妇科肿瘤患者中的临床价值。
Cancer. 1985 Jun 1;55(11):2618-23. doi: 10.1002/1097-0142(19850601)55:11<2618::aid-cncr2820551114>3.0.co;2-s.
7
[The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].[组织多肽抗原(TPA)在妇科肿瘤患者中的临床意义]
Nihon Sanka Fujinka Gakkai Zasshi. 1984 May;36(5):779-84.
8
Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.组织多肽抗原(TPA)和癌胚抗原(CEA)在乳腺癌中的免疫细胞化学定位差异
Cancer Detect Prev. 1983;6(1-2):193-8.
9
Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.结肠肿瘤中的组织多肽抗原和癌胚抗原:血清水平及免疫组化定位
Cancer Detect Prev. 1985;8(1-2):219-26.
10
[A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].[一项关于定位及血清数据的研究;卵巢癌中的四种肿瘤标志物(CA125、CA19-9、CEA和TPA)]
Nihon Gan Chiryo Gakkai Shi. 1990 Jan 20;25(1):47-54.

本文引用的文献

1
Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.采用细胞免疫学技术检测人恶性组织和正常组织混合样本的抗原性;存在一种不溶性、热不稳定的肿瘤抗原。
Int Arch Allergy Appl Immunol. 1957;10(3):153-84.
2
Biochemical properties of tissue polypeptide antigen.
Biochim Biophys Acta. 1980 Jul 24;624(1):90-101. doi: 10.1016/0005-2795(80)90228-7.
3
Ovarian cancer. Geographical, host and environmental factors. An overview.卵巢癌。地理、宿主及环境因素。综述。
Arch Gynecol. 1983;234(2):137-48. doi: 10.1007/BF00207686.
4
Chemical studies of tissue polypeptide antigen (TPA). III. on the nature of the antigenic determinant(s) of TPA subfraction B1.组织多肽抗原(TPA)的化学研究。III. 关于TPA亚组分B1抗原决定簇的性质
Acta Chem Scand B. 1981;35(5):325-36. doi: 10.3891/acta.chem.scand.35b-0325.
5
The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.组织多肽抗原在妇科肿瘤患者中的临床价值。
Cancer. 1985 Jun 1;55(11):2618-23. doi: 10.1002/1097-0142(19850601)55:11<2618::aid-cncr2820551114>3.0.co;2-s.
6
Cancer statistics, 1988.1988年癌症统计数据。
CA Cancer J Clin. 1988 Jan-Feb;38(1):5-22. doi: 10.3322/canjclin.38.1.5.
7
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.对癌症或良性肿瘤患者血清或尿液(或两者)中的组织多肽抗原进行初步评估。
Clin Chem. 1978 Jun;24(6):868-72.